AN OUNCE OF PREVENTION
The impact of SRD as early as the nursery stage can even funnel to the finisher and packer, journeying inside animals that beat the mortality odds. It has been estimated that for every 10% of lung area permanently affected by a respiratory infection, average daily gain (ADG) decreases by 0.08 pound.1
NURSERY LUNG ATTACHMENT'S IMPACT ON GROW/FINISH RATE OF WEIGHT GAIN1
FURTHER ECONOMIC IMPLICATIONS OF SRD
Diseases are costly and impactful on their own — but what about when you compound multiple challenges? The additive cost of pathogen combinations can grow rapidly. This economic impact is calculated based on a number of factors, including an increase in mortality, culls, and tailenders (MCT) and a reduction in average daily gain (ADG). The impact of multiple challenges is exponential — combined challenges can double or triple the economic impact on your bottom line.2
OBSERVE YOUR HERD
Once clinical signs of illness are visible in one animal, infection may have already spread through the barn, so early response is critical. One of the earliest symptoms of potential SRD infection is a drop in 24-hour water consumption, which you may see even before clinical signs such as lethargy, coughing, sneezing, nasal and ocular discharge, thumping, fever, and reduced feed intake are apparent.
So, addressing potential stressors early is important — especially in the nursery — to help alleviate the unavoidable stresses from weaning, transportation, or commingling. Understanding definite issues you have had in the past with air, water, feed, and the space itself, for example, helps inform how to possibly prepare the space for incoming animals.
Unfortunately, even the most protected barns are likely to experience some level of SRD challenge, so there are different potential strategies producers and veterinarians employ for prevention and treatment. You should do a solid assessment of specific variables before choosing a treatment path:
ASSESSING THE SRD SITUATION
> Is this an individual or whole herd issue?
> Have diagnostics been performed?
> Are clinical signs and symptoms currently being presented?
> What environmental stressors may be playing a part?
> What does the herd’s health history look like?
> How have these clinical signs been addressed in the past?
Every pathogen involved in the SRD complex causes its own set of challenges, but two stand out by causing a more widespread impact on our industry — PRRS and M. hyo. Because of this, we have additional resources and materials available below to take a stand against these infections:
It makes sense to invest in quality locks for the doors and windows of your house — and maybe even an alarm system — to keep out unwanted intruders. The same principle applies to your operation in defense against the SRD complex. You need the proper tools to protect against and ward off these pathogens.
Immune support, preventive measures, and quick interventions against SRD are essential to not only your herd’s health but to the health of your bottom line. Protect your investment with Elanco’s portfolio of potential to address common respiratory ailments.
ADDITIONAL RESOURCES
The labels contain complete use information, including cautions and warnings. Always read, understand and follow the label and use directions.
PULMOTIL® AC IMPORTANT SAFETY INFORMATION:
Before using this product, it is important to read the entire product insert, including the boxed human warning.
WARNING: Exposure to tilmicosin in humans has been associated with chest pain, increased heart rate, dizziness, headache, and nausea. Death has been reported following ingestion or injection of tilmicosin. Avoid direct skin and eye contact. In case of human exposure, call 1-800-722-0987 and consult a physician immediately.
- Wear overalls, impervious gloves and eye protection when mixing and handling the product. Wash hands after handling the product. Wash affected parts if skin contact occurs. If accidental eye contact occurs, immediately rinse thoroughly with water.
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
- For use only in swine. Not for injection. Injection of tilmicosin has been shown to be fatal in swine and non-human primates, and may be fatal in horses and goats.
- Swine intended for human consumption must not be slaughtered within 7 days of treatment.
- Always treat the fewest number of animals necessary to control a respiratory disease outbreak. Prescriptions shall not be refilled.
- Concurrent use of Pulmotil AC and another macrolide by any route, or use of another macrolide immediately following this use of Pulmotil AC is not advised.
- Ensure that pigs have continuous access to medicated water during the treatment period. Monitor pigs for signs of water refusal and dehydration while being treated.
BAYTRIL® IMPORTANT SAFETY INFORMATION:
CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. Federal (U.S.A.) law prohibits the extra-label use of this drug in food-producing animals. To assure responsible antimicrobial drug use, enrofloxacin should only be used as a second-line drug for colibacillosis in swine following consideration of other therapeutic options.
- Not for use in humans. Keep out of reach of children.
- Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for 15 minutes.
- In case of dermal contact, wash skin with soap and water. Consult a physician if irritation persists following ocular or dermal exposures.
- Individuals with a history of hypersensitivity to quinolones should avoid this product. In humans, there is a risk of user photosensitization within a few hours after excessive exposure to quinolones. If excessive accidental exposure occurs, avoid direct sunlight.
INCREXXATM IMPORTANT SAFETY INFORMATION:
- CAUTION: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.
- WARNINGS: FOR USE IN ANIMALS ONLY. NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN. NOT FOR USE IN CHICKENS OR TURKEYS.
- Swine intended for human consumption must not be slaughtered within 5 days from the last treatment.
- The effects of Increxxa on porcine reproductive performance, pregnancy, and lactation have not been determined.
- Intramuscular injection can cause a transient local tissue reaction that may result in trim loss of edible tissue at slaughter.
- Store below 25°C (77°F), with excursions up to 40°C (104°F).
- 100 mL: Use within 2 months of first puncture and puncture a maximum of 67 times. If more than 67 punctures are anticipated, the use of multi-dosing equipment is recommended. When using a draw-off spike or needle with bore diameter larger than 16 gauge, discard any product remaining in the vial immediately after use.
- 250 mL and 500 mL: Use within 2 months of first puncture and puncture a maximum of 100 times. If more than 100 punctures are anticipated, the use of multi-dosing equipment is recommended. When using a draw-off spike or needle with bore diameter larger than 16 gauge, discard any product remaining in the vial immediately after use.
PRADALEXTM IMPORTANT SAFETY INFORMATION:
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in humans. Keep out of reach of children. Avoid contact with eyes and skin. Individuals with a history of hypersensitivity to quinolones should avoid this product. Not for use in animals intended for breeding because the effects of Pradalex on swine reproductive performance, pregnancy and lactation have not been determined. Not for use in nursing piglets because safety and effectiveness have not been demonstrated. Quinolones should be used with caution in animals with known or suspected central nervous system (CNS) disorders. Mild to moderate inflammatory changes of the injection site may be seen in swine treated with Pradalex. See package insert for additional safety information.
TYLAN® INJECTION IMPORTANT SAFETY INFORMATION:
WARNING: NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN.
- Adverse reactions, including shock and death may result from overdosage in baby pigs. Do not attempt injection into pigs weighing less than 25 pounds (0.5 mL) with the common syringe. It is recommended that Tylan 50 Injection be used in pigs weighing less than 25 pounds.
- Do not administer to horses or other equines. Injection of tylosin in equines has been fatal.
- Swine intended for human consumption must not be slaughtered within 14 days of the last use of this drug product.
- If tylosin medicated drinking water is used as a follow-up treatment for swine dysentery, the animal should thereafter receive feed containing 40 to 100 grams of tylosin per ton for 2 weeks to assure depletion of tissue residues.
